| Literature DB >> 27227649 |
Zhigang Bai1, Xiaofen Ma2, Junzhang Tian2, Jianwei Dong3, Jinlong He4, Wenfeng Zhan2, Lijuan Xu5, Yikai Xu1, Guihua Jiang2.
Abstract
PURPOSE: To study whole-brain microstructural alterations in patients with end-stage renal disease (ESRD) and examine the relationship between brain microstructure and physiological indictors in the disease.Entities:
Mesh:
Year: 2016 PMID: 27227649 PMCID: PMC4881995 DOI: 10.1371/journal.pone.0155902
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics and clinical characteristics of all participants.
| ESRD (n = 35) | HCs (n = 40) | P-value | |
|---|---|---|---|
| Gender (M/F) | 28/7 | 32/8 | >0.999 |
| Age (yrs) | 37.5±11.3 (18–61) | 41.5±10.6 (22–58) | 0.119 |
| Education level (yrs) | 11.8±3.2 (3–16) | 10.8±2.8 (6–18) | 0.148 |
| MMSE | 26.9±1.9 (22–30) | 29.5±0.9 (26–30) | <0.001 |
| Dialysis duration (mths) | 15.5±6.6 (6–30) | - | - |
| Blood systolic pressure | 158.5±19.5 (120–190) | 102.2±8.8 (90–120) | <0.001 |
| Blood diastolic pressure | 90.0±11.1 (60–110) | 70±6.4 (60–80) | <0.001 |
| Serum calcium (mmol/L) | 2.3±0.2 (1.9–2.9) | 2.3±0.2 (2.1–2.7) | 0.535 |
| Serum kalium (mmol/L) | 4.5±0.9 (2.9–6.3) | 4.3±1.0 (2.2–6.3) | 0.317 |
| Hemoglobin (g/L) | 102.5±23.5 (56–158) | 107.3±9.7 (88–124) | 0.357 |
| Serum creatinine (μmol/L) | 838.1±483.6 (80–2030) | 168.7.1±213.8 (58–920) | <0.001 |
| Blood urea nitrogenurea (mmol/L) | 17.8±8.2 (4.1–30.2) | 5.6±1.4 (2.8–7.3) | <0.001 |
| Cholesterol (mmol/L) | 5.1±1.4 (3.7–9.9) | 3.9±0.4 (3.1–4.8) | <0.001 |
Values are represented as mean±SD (min-max). ESRD, end-stage renal disease; HCs, healthy controls.
aThe P-value was obtained by a chi-square test.
bThe P-values were obtained by two-side two-sample t-tests.
cData were missing for six patients.
Fig 1Decreased FA in the patients with ESRD as compared with HCs. R, right.
Fig 2Increased MD in the patients with ESRD as compared with HCs. R, right.
Fig 3Increased AD in the patients with ESRD as compared with HCs. R, right.
Fig 4Increased RD in the patients with ESRD as compared with HCs. R, right.
Fig 5The relationships between DTI metrics and biochemical indictors in the ESRD patients. R, right.